About
cystetic Medicines develops molecular prosthetics therapy to restore airway function in cystic fibrosis patients who have mutations producing little-to-no CFTR protein and cannot benefit from existing modulators.
Explore cystetic Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.